Literature DB >> 29662389

Y chromosome and new concept of azoospermia factor.

Eitetsu Koh1, Jin Choi1, Mikio Namiki1.   

Abstract

The completion of a draft sequence of the entire human genome in 2001 was followed by a complete sequencing of the Y chromosome in 2003. It is now possible to refer to a physical map of the Y chromosome. The Y chromosome can be classified into X-transposed, X-degenerate and ampliconic sequences depending on the origins of its sequences. In particular, the ampliconic sequences are complexes of massive palindrome structures in which sequences having higher than 99.9% homology are present symmetrically. Interestingly, palindromic repeats may undergo frequent gene conversion associated with intrachromosomal recombination and play an important role in the maintenance of the genetic materials of the Y chromosome. The azoospermia factor (AZF) region of the ampliconic region is the most probable candidate for spermatogenesis, and forms a palindrome structure. Thus, there is a limit in the detection of microdeletion using conventional sequence-tagged sites based on polymerase chain reaction because of their structure. It is now necessary to update the AZF concept. (Reprod Med Biol 2005; 4: 123-128).

Entities:  

Keywords:  Y chromosome; azoospermia factor; male infertility; palindrome

Year:  2005        PMID: 29662389      PMCID: PMC5891733          DOI: 10.1111/j.1447-0578.2005.00097.x

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  32 in total

1.  Screening for microdeletions of Y chromosome genes in patients undergoing intracytoplasmic sperm injection.

Authors:  C Krausz; C Bussani-Mastellone; S Granchi; K McElreavey; G Scarselli; G Forti
Journal:  Hum Reprod       Date:  1999-07       Impact factor: 6.918

2.  EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004.

Authors:  M Simoni; E Bakker; C Krausz
Journal:  Int J Androl       Date:  2004-08

3.  Prevalence of Y chromosome microdeletions in infertile men who consulted a tertiary care medical centre: the Münster experience.

Authors:  B Maurer; J Gromoll; M Simoni; E Nieschlag
Journal:  Andrologia       Date:  2001-01       Impact factor: 2.775

4.  Three-generation evaluation of Y-chromosome microdeletion.

Authors:  S E Kleiman; L Yogev; R Gamzu; R Hauser; A Botchan; G Paz; J B Lessing; Y Yaron; H Yavetz
Journal:  J Androl       Date:  1999 May-Jun

5.  Transmission of de novo mutations of the deleted in azoospermia genes from a severely oligozoospermic male to a son via intracytoplasmic sperm injection.

Authors:  M C Jiang; Y R Lien; S U Chen; T M Ko; H N Ho; Y S Yang
Journal:  Fertil Steril       Date:  1999-06       Impact factor: 7.329

6.  Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure.

Authors:  Sjoerd Repping; Helen Skaletsky; Julian Lange; Sherman Silber; Fulco Van Der Veen; Robert D Oates; David C Page; Steve Rozen
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

7.  The human Y chromosome: a 43-interval map based on naturally occurring deletions.

Authors:  D Vollrath; S Foote; A Hilton; L G Brown; P Beer-Romero; J S Bogan; D C Page
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

8.  Case report: natural transmission of an AZFc Y-chromosomal microdeletion from father to his sons.

Authors:  B Kühnert; J Gromoll; E Kostova; P Tschanter; C M Luetjens; M Simoni; E Nieschlag
Journal:  Hum Reprod       Date:  2004-03-11       Impact factor: 6.918

9.  AZF microdeletions of the Y chromosome and in vitro fertilization outcome.

Authors:  Janet M Choi; Pak Chung; Lucinda Veeck; Anna Mielnik; Gianpiero D Palermo; Peter N Schlegel
Journal:  Fertil Steril       Date:  2004-02       Impact factor: 7.329

10.  The human Y chromosome's azoospermia factor b (AZFb) region: sequence, structure, and deletion analysis in infertile men.

Authors:  A Ferlin; E Moro; A Rossi; B Dallapiccola; C Foresta
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.